HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

IMCR

Immunocore Holdings plc ADR

Last Close
Apr 25 • 04:00PM ET
30.16
Dollar change
-0.20
Percentage change
-0.66 		%
Healthcare • Biotechnology • United Kingdom • NASD
Peers: MRNA REGN AMGN VRTX BIIB BNTX BMY GILD INCY NVAX
 | Held by: IBB SPDW SBIO GWX ONEQ CANC BBP ISCF GINN CNCR
Scroll to Statements
Index- P/E- EPS (ttm)-1.03 Insider Own2.74% Shs Outstand50.06M Perf Week6.16%
Market Cap1.51B Forward P/E- EPS next Y-1.89 Insider Trans143.07% Shs Float48.69M Perf Month2.34%
Income-50.78M PEG- EPS next Q-0.38 Inst Own89.74% Short Float15.77% Perf Quarter-8.61%
Sales310.29M P/S4.87 EPS this Y-53.24% Inst Trans2.11% Short Ratio24.85 Perf Half Y-9.46%
Book/sh7.16 P/B4.21 EPS next Y-20.73% ROA-6.32% Short Interest7.68M Perf Year-47.37%
Cash/sh16.39 P/C1.84 EPS next 5Y-20.72% ROE-13.92% 52W Range23.15 - 62.74 Perf YTD2.24%
Dividend Est.- P/FCF72.24 EPS past 5Y- ROI-6.41% 52W High-51.93% Beta0.74
Dividend TTM- Quick Ratio4.36 Sales past 5Y92.63% Gross Margin97.76% 52W Low30.28% ATR (14)1.75
Dividend Ex-Date- Current Ratio4.38 EPS Y/Y TTM10.51% Oper. Margin-22.68% RSI (14)59.11 Volatility6.94% 6.63%
Employees493 Debt/Eq1.20 Sales Y/Y TTM24.19% Profit Margin-16.36% Recom1.71 Target Price63.24
Option/ShortYes / Yes LT Debt/Eq1.20 EPS Q/Q-17.12% Payout- Rel Volume0.81 Prev Close30.36
Sales Surprise-0.52% EPS Surprise-107.60% Sales Q/Q17.66% EarningsFeb 26 BMO Avg Volume309.10K Price30.16
SMA207.20% SMA504.13% SMA200-6.25% Trades Volume251,246 Change-0.66%
Date Action Analyst Rating Change Price Target Change
Dec-13-24Downgrade Morgan Stanley Overweight → Equal-Weight $74 → $35
Nov-11-24Downgrade Mizuho Outperform → Neutral $72 → $38
Oct-24-24Initiated UBS Sell $24
Oct-07-24Downgrade Guggenheim Buy → Neutral
Apr-29-24Initiated Leerink Partners Outperform $74
Nov-20-23Resumed JP Morgan Overweight $60
Nov-02-23Initiated Cantor Fitzgerald Overweight
Oct-31-23Initiated Robert W. Baird Outperform $84
Sep-13-23Upgrade JP Morgan Neutral → Overweight $9 → $22
Sep-13-23Initiated Needham Buy $75
Show Previous Ratings
Apr-02-25 11:49AM
Hospitals Experience FOMO In Adopting Delcath's PHP Treatment
(Seeking Alpha)
08:00AM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Mar-25-25 10:46AM
Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March
(InsiderMonkey)
Mar-21-25 10:21AM
Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?
(Zacks)
Mar-10-25 03:00PM
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
(GlobeNewswire)
07:00AM Loading…
Mar-03-25 07:00AM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Feb-27-25 02:07AM
Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
(GuruFocus.com)
02:02AM
Q4 2024 Immunocore Holdings PLC Earnings Call
(Thomson Reuters StreetEvents)
Feb-26-25 07:00AM
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
(GlobeNewswire) +5.34%
Feb-25-25 10:32AM
Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result
(GuruFocus.com)
Feb-20-25 03:00AM
Lillys former M&A chief scours the landscape for potential deals as Immunocores new CFO
(Pharma Voice)
Feb-19-25 07:00AM
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
(GlobeNewswire)
Jan-13-25 09:55AM
Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade
(Zacks)
Jan-10-25 07:00AM
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Jan-06-25 07:00AM
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
07:00AM Loading…
Jan-02-25 07:00AM
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
(GlobeNewswire)
Dec-23-24 07:00AM
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
(GlobeNewswire)
Dec-18-24 11:34AM
Immunocore doses first subject in gastrointestinal cancer therapy trial
(Clinical Trials Arena)
Dec-17-24 07:00AM
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
(GlobeNewswire)
Dec-13-24 02:10PM
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
(Benzinga)
Dec-12-24 12:00PM
All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy
(Zacks)
07:12AM
Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial
(TipRanks)
Dec-11-24 07:00AM
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
(GlobeNewswire)
Dec-03-24 01:00AM
Immunocore announces reimbursement agreement in England for KIMMTRAK? for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
(GlobeNewswire)
Nov-28-24 09:55AM
Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?
(Zacks)
Nov-19-24 08:58AM
Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode
(Insider Monkey)
Nov-18-24 08:25AM
Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?
(Insider Monkey)
Nov-08-24 09:55AM
Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know
(Zacks)
07:00AM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Nov-06-24 07:00AM
Immunocore reports third quarter financial results and provides a business update
(GlobeNewswire)
12:00PM Loading…
Nov-05-24 12:00PM
Immunocore (IMCR) Upgraded to Buy: Here's Why
(Zacks) +5.84%
Oct-09-24 05:31PM
Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...
(GuruFocus.com)
Sep-29-24 07:43AM
Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now
(Insider Monkey)
Sep-27-24 05:17AM
Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy
(Insider Monkey)
Sep-25-24 11:29AM
Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales
(Insider Monkey)
Sep-14-24 05:12PM
Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock
(Insider Monkey)
03:00AM
Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer
(GlobeNewswire)
Sep-12-24 04:05PM
Immunocore to present at the 2024 Cantor Global Healthcare Conference
(GlobeNewswire)
01:30AM
Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ...
(GuruFocus.com)
Sep-05-24 08:30AM
Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics
(PR Newswire)
Aug-30-24 01:16AM
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds
(Insider Monkey)
Aug-29-24 07:00AM
Immunocore announces transition of Chief Financial Officer
(GlobeNewswire)
Aug-08-24 07:00AM
Immunocore reports second quarter financial results and provides a business update
(GlobeNewswire)
Aug-06-24 10:41AM
3 Small-Cap Stocks with Significant Growth Potential
(InvestorPlace)
Aug-01-24 07:00AM
Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
(GlobeNewswire)
Jun-18-24 07:00AM
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
(GlobeNewswire)
Jun-01-24 08:00AM
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
(GlobeNewswire)
May-31-24 04:05PM
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
(GlobeNewswire) -12.74%
May-30-24 04:00PM
Immunocore to present at the Jefferies Global Healthcare Conference
(GlobeNewswire)
May-29-24 07:00AM
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
(GlobeNewswire)
May-24-24 12:00PM
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
(Barrons.com)
May-08-24 01:54PM
IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024
(InvestorPlace)
09:35AM
Immunocore Holdings' Shares Fall After Q1 Net Loss Widens
(MT Newswires)
08:38AM
Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
(GuruFocus.com)
07:00AM
Immunocore reports first quarter financial results and provides a business update
(GlobeNewswire)
Apr-29-24 07:15AM
Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target
(MT Newswires)
Apr-24-24 10:00AM
Immunocore announces upcoming presentation and posters at ASCO 2024
(GlobeNewswire)
Apr-04-24 04:00PM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Mar-13-24 11:07AM
Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio
(InvestorPlace)
Mar-05-24 04:30PM
Immunocore presented two posters at CROI 2024
(GlobeNewswire)
Mar-01-24 07:00AM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Feb-29-24 10:51AM
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript
(Insider Monkey)
Feb-28-24 04:53PM
Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ...
(GuruFocus.com)
07:34AM
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
(GlobeNewswire)
Feb-22-24 07:00AM
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
(GlobeNewswire)
Feb-21-24 07:00AM
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
(GlobeNewswire)
Feb-01-24 09:00AM
DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay
(PR Newswire)
05:16AM
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
(Zacks)
Jan-30-24 11:30PM
Immunocore Prices Upsized Convertible Senior Notes Offering
(GlobeNewswire) -6.19% +6.87%
Jan-29-24 04:05PM
Immunocore Announces Proposed Convertible Senior Notes Offering
(GlobeNewswire)
Jan-10-24 09:55AM
Should You Buy Immunocore Holdings PLC Sponsored ADR (IMCR) After Golden Cross?
(Zacks)
Jan-09-24 01:51PM
Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets.
(Barrons.com) +5.95%
Jan-05-24 07:00AM
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
(GlobeNewswire)
Jan-03-24 07:00AM
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-18-23 12:00PM
Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know
(Zacks)
Dec-13-23 09:55AM
How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32%
(Zacks)
Nov-30-23 04:00AM
Levicept Appoints Eliot Forster as CEO
(GlobeNewswire) +6.83%
Nov-27-23 09:55AM
Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?
(Zacks)
Nov-20-23 09:55AM
Bears are Losing Control Over Immunocore Holdings PLC Sponsored ADR (IMCR), Here's Why It's a 'Buy' Now
(Zacks)
Nov-14-23 09:09AM
11 Best Undervalued UK Stocks To Buy Now
(Insider Monkey)
Nov-10-23 09:55AM
Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
(Zacks)
Nov-07-23 07:00AM
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire) +5.71%
Nov-01-23 04:01PM
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
(GlobeNewswire)
Oct-30-23 04:30PM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Oct-21-23 08:45AM
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
(GlobeNewswire)
Oct-19-23 09:55AM
Wall Street Analysts See a 60.86% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
(Zacks)
Oct-07-23 03:33PM
12 Stock Picks From Our Healthcare Roundtable Pros. Weight Loss Isnt the Only Big Deal in Medicine.
(Barrons.com)
Oct-06-23 07:01AM
Immunocore announces upcoming presentation and posters at ESMO 2023
(GlobeNewswire)
Sep-22-23 06:40PM
Cardlytics, Immunocore, and More Stocks See Action From Activist Investors
(Barrons.com)
Sep-14-23 02:02PM
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
(Insider Monkey)
Sep-11-23 05:00PM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Sep-01-23 04:00PM
Immunocore to present at upcoming investor conferences
(GlobeNewswire)
Aug-13-23 07:15AM
Immunocore Holdings plc (NASDAQ:IMCR) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-10-23 10:22PM
Q2 2023 Immunocore Holdings PLC Earnings Call
(Thomson Reuters StreetEvents)
07:00AM
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire)
Aug-08-23 08:48AM
Why Earnings Season Could Be Great for Immunocore (IMCR)
(Zacks)
Aug-03-23 08:00AM
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
(GlobeNewswire)
Jul-18-23 06:05AM
Immunocore Holdings (NASDAQ:IMCR) shareholders have earned a 41% return over the last year
(Simply Wall St.)
Jun-07-23 06:59AM
With 45% stake, Immunocore Holdings plc (NASDAQ:IMCR) seems to have captured institutional investors' interest
(Simply Wall St.)
Jun-03-23 07:00AM
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
(GlobeNewswire)
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX - Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAKER BROS. ADVISORS LPDirectorMar 17 '25Buy29.72807,33823,993,2242,144,060Mar 19 06:40 PM
Brian Di DonatoaffiliateMar 17 '25Proposed Sale30.00100,0003,000,000Mar 17 04:24 PM
Brian Di DonatoaffiliateMar 14 '25Proposed Sale29.1356,2501,638,511Mar 14 05:08 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • theme settings • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.